GOF mutations in STING underlie a type I interferonopathy termed STING-associated vasculopathy with onset in infancy (SAVI), which is variably characterized by early-onset systemic inflammation, skin vasculopathy and interstitial lung disease. Here, STING1 is linked to STING-associated vasculopathy with onset in infancy.